In the present study, we, therefore, examine the correlation between BHLHE41 expression and the prognosis of patients with NSCLC and explored the potential roles of BHLHE41 as a tumor suppressor during lung cancer development and progression. The gene discussed is BHLHE41; the disease is lung cancer.